Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells

Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells

Background: Senescent cells accumulate in tissues over time as part of the natural ageing process and the removal of senescent cells has shown promise for alleviating many different age-related diseases in mice. Cancer is an age-associated disease and there are numerous mechanisms driving cellular s...

Full description

Bibliographic Details
Main Authors:	Hillary H. Le, Suleyman S. Cinaroglu, Elise C. Manalo, Aysegul Ors, Michelle M. Gomes, Burcin Duan Sahbaz, Karla Bonic, Carlos A. Origel Marmolejo, Arnaud Quentel, Justin S. Plaut, Taryn E. Kawashima, E. Sila Ozdemir, Sanjay V. Malhotra, Yavuz Ahiska, Ugur Sezerman, Gunseli Bayram Akcapinar, Joshua C. Saldivar, Emel Timucin, Jared M. Fischer
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	EBioMedicine
Subjects:	Senolytic FOXO4 TP53 Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396421004394

Similar Items

Moving senolytics closer to the clinic in IPF
by: Daniel Kramer, et al.
Published: (2023-04-01)

Senolytics as drugs or fashionable dietary supplements
by: Małgorzata Starek, et al.
Published: (2021-05-01)

Senolytics in the treatment of diabetic retinopathy
by: Jannah Waled Hassan, et al.
Published: (2022-08-01)

An Appraisal on the Value of Using Nutraceutical Based Senolytics and Senostatics in Aging
by: Amanpreet Kaur, et al.
Published: (2020-04-01)

Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging
by: Harikrishnan Thoppil, et al.
Published: (2020-01-01)

Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
by: Valerie J. Carpenter, et al.
Published: (2021-02-01)

Impact of Senolytic Treatment on Gene Expression in Aged Lung
by: Soo Jung Cho, et al.
Published: (2023-04-01)

Senolytics: A Novel Strategy for Neuroprotection in ALS?
by: Alexandra Maximova, et al.
Published: (2021-11-01)

Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
by: Li Hu, et al.
Published: (2022-02-01)

Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
by: Natalie Kudlova, et al.
Published: (2022-04-01)

Impact of senolytic treatment on immunity, aging, and disease
by: Erica C. Lorenzo, et al.
Published: (2023-10-01)

Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice
by: Edward Fielder, et al.
Published: (2022-05-01)

Chemoinformatic Screening for the Selection of Potential Senolytic Compounds from Natural Products
by: Oscar Salvador Barrera-Vázquez, et al.
Published: (2021-03-01)

Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice
by: Yanghuan Zhang, et al.
Published: (2023-03-01)

Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin
by: Marco Raffaele, et al.
Published: (2021-04-01)

Inhibitor PF-04691502 works as a senolytic to regulate cellular senescence
by: Ziqiang Fan, et al.
Published: (2024-02-01)

Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics
by: Lea Beltzig, et al.
Published: (2022-08-01)

Senolytic treatment with dasatinib and quercetin does not improve overall influenza responses in aged mice
by: Blake L. Torrance, et al.
Published: (2023-06-01)

Rationale and design of STAMINA: Senolytics to alleviate mobility issues and neurological impairments in aging, a geroscience feasibility study
by: Courtney L. Millar, et al.
Published: (2023-01-01)

Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation
by: David Hernández-Silva, et al.
Published: (2022-09-01)

Tissue-Specific Metabolic Regulation of FOXO-Binding Protein: FOXO Does Not Act Alone
by: Noriko Kodani, et al.
Published: (2020-03-01)

Augmentation of Bone Regeneration by Depletion of Stress-Induced Senescent Cells Using Catechin and Senolytics
by: Yoshitomo Honda, et al.
Published: (2020-06-01)

Identification of Senescent Cells in Peri-Implantitis and Prevention of Mini-Implant Loss Using Senolytics
by: Niuxin Yang, et al.
Published: (2023-01-01)

A focused natural compound screen reveals senolytic and senostatic effects of Isatis tinctoria
by: Eun-Jung Kim, et al.
Published: (2022-11-01)

Nutritional senolytics and senomorphics: Implications to immune cells metabolism and aging – from theory to practice
by: Carla Luís, et al.
Published: (2022-09-01)

Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer
by: Lian Wang, et al.
Published: (2024-05-01)

Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells
by: Tareq Saleh, et al.
Published: (2022-12-01)

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerabilityResearch in context
by: Anoop Nambiar, et al.
Published: (2023-04-01)

From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
by: Valentin L'Hôte, et al.
Published: (2022-09-01)

Enhancement of Bone-Forming Ability on Beta-Tricalcium Phosphate by Modulating Cellular Senescence Mechanisms Using Senolytics
by: Xinchen Wang, et al.
Published: (2021-11-01)

Effects of senolytic drugs on human mesenchymal stromal cells
by: Clara Grezella, et al.
Published: (2018-04-01)

The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells
by: Abrar Softah, et al.
Published: (2023-11-01)

DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity
by: Nicolas Malaquin, et al.
Published: (2020-07-01)

Elimination of Senescent Cells by Senolytics Facilitates Bony Endplate Microvessel Formation and Mitigates Disc Degeneration in Aged Mice
by: Bolin Chen, et al.
Published: (2022-07-01)

Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction
by: Tareq Saleh, et al.
Published: (2020-10-01)

Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics
by: Keisuke Okuno, et al.
Published: (2020-09-01)

The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice
by: Anuj K. Sharma, et al.
Published: (2020-05-01)

Exploring the perspectives of pharmaceutical experts and healthcare practitioners on senolytic drugs for vascular aging-related disorder: a qualitative study
by: Li Ping Wong, et al.
Published: (2023-10-01)

Senolytic therapy is neuroprotective and improves functional outcome long-term after traumatic brain injury in mice
by: Jing Wang, et al.
Published: (2023-07-01)

Senolytic Flavonoids Enhance Type-I and Type-II Cell Death in Human Radioresistant Colon Cancer Cells through AMPK/MAPK Pathway
by: Maria Russo, et al.
Published: (2023-05-01)